• In the past week, Leidos Holdings reported Q2 2026 results showing sales rising to US$4.56 billion while net income and earnings per share eased year over year, alongside a modest increase in full‑year 2026 revenue guidance to US$18.20 billion–US$18.40 billion and the reaffirmation of dividends and a new share repurchase authorization.
• At the same time, the company secured sizeable new defense and intelligence work, from hypersonic missile tracking satellites to extended ISR and naval intelligence contracts, and advanced its AI capabilities through a CoreWeave partnership and the launch of its Parcata cyber platform, reinforcing its push into higher‑value, technology‑heavy national security solutions.
• Next, we’ll examine how raised full‑year guidance, underpinned by these new defense and AI contracts, reshapes Leidos’s existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Leidos Holdings Investment Narrative Recap

To own Leidos, you have to believe its focus on defense, intelligence and AI can translate contract momentum into durable earnings despite reliance on U.S. government budgets. Q2 2026 delivered higher revenue but lower net income, so the key near term catalyst is whether raised 2026 guidance proves achievable. The biggest risk still looks like funding and procurement shifts in core federal agencies, and this week’s news does not materially change that.

Among the recent announcements, the new AMDT3 hypersonic missile tracking work with Sierra Space stands out. It ties directly to Leidos’ push into higher value, technology heavy defense programs that underpin its upgraded 2026 revenue outlook of US$18.20 billion to US$18.40 billion. For investors, this kind of multi satellite, AI enabled sensing contract helps bridge the gap between headline guidance and the actual backlog needed to support it.

Yet even with these wins, investors should be aware that reliance on evolving U.S. defense and cyber budgets could still...

Leidos Holdings' narrative projects $20.3 billion revenue and $1.7 billion earnings by 2029. This requires 5.4% yearly revenue growth and about a $0.3 billion earnings increase from $1.4 billion today.

Uncover how Leidos Holdings' forecasts yield a $165.27 fair value, a 30% upside to its current price.

Exploring Other Perspectives

Some of the lowest analysts were assuming Leidos would reach only about US$19.7 billion of revenue and US$1.6 billion of earnings by 2029, so if you see fresh AI and defense contracts as proof that cyber demand can stay stronger for longer, you may view that more pessimistic narrative very differently.

Explore 3 other fair value estimates on Leidos Holdings - why the stock might be worth just $148.27!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Leidos Holdings research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Leidos Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Leidos Holdings' overall financial health at a glance.

Contemplating Other Strategies?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.